---
id: 1196105411671314432
author:stephensenn
published_date:{{PUBLISHED_DATE }}
conversation_id: Conversation-1195180096505577472
in_reply_to: 1196103009681444865
retweet: None
quoted_tweet: None
---

@f2harrell @yudapearl @RonKenett @learnfromerror In general a blocking factor is chosen because a) it is considered predictive and b) it is practical to block. For single dose trials in asthma 'patient' is perfect. You run a cross-over trial &amp; all genetic &amp; environmental factors are controlled for. Its not possible in cancer.

### Metadata

Author: [[@stephensenn]]
Conversation: [[Conversation-1195180096505577472]]
In reply to: [[1196103009681444865]]
Retweet of: [[None]]
Quoted tweet: [[None]]
